Peptides derived from NCAM (FGLs)
    2.
    发明授权
    Peptides derived from NCAM (FGLs) 有权
    衍生自NCAM(FGL)的肽

    公开(公告)号:US08470964B2

    公开(公告)日:2013-06-25

    申请号:US12745129

    申请日:2008-11-28

    IPC分类号: C07K2/00 A61K38/00

    CPC分类号: C07K14/70503 A61K38/00

    摘要: The present invention relates to novel compounds comprising at most 13 contiguous amino acid residues derived from the fibronectin type 3,11 module of neural cell adhesion molecule (NCAM), or a variant or fragment thereof, capable of interacting with an FGFR and thereby the compounds are capable of inducing differentiation, modulating proliferation, stimulate regeneration, neuronal plasticity or survival of cells. Further, the present invention relates to the use of the compounds for production of a medicament for treatment of conditions and diseases, in which NCAM or FGFR play a prominent role.

    摘要翻译: 本发明涉及包含至少13个连续氨基酸残基的新化合物,其衍生自神经细胞粘附分子(NCAM)的3型纤连蛋白模块或其变体或片段,其能够与FGFR相互作用,从而使化合物 能够诱导分化,调节增殖,刺激再生,神经元可塑性或细胞存活。 此外,本发明涉及该化合物用于制备用于治疗NCAM或FGFR起重要作用的病症和疾病的药物的用途。

    Method of modulating cell survival, differentiation and/or synaptic plasticity
    3.
    发明授权
    Method of modulating cell survival, differentiation and/or synaptic plasticity 有权
    调节细胞存活,分化和/或突触可塑性的方法

    公开(公告)号:US07847058B2

    公开(公告)日:2010-12-07

    申请号:US10574084

    申请日:2004-09-29

    IPC分类号: A61K38/00 C07K4/00

    摘要: The present invention relates to a method of modulating differentiation, adhesion and/or survival of the neural cell adhesion molecule (NCAM) presenting cells by providing compounds capable of modulating the interaction between the Ig1, Ig2 and/or Ig3 modules of NCAM. The invention provides candidate compounds capable of modulating the interaction between the Ig1, Ig2 and/or Ig3 modules of NCAM by using methods for screening and testing described in the application. The invention further relates to pharmaceutical compositions comprising compounds capable of modulating the interaction between the Ig1, Ig2 and/or Ig3 modules of NCAM and to use of the pharmaceutical compositions and compounds for the modulation of differentiation, adhesion and/or survival of NCAM presenting cells.

    摘要翻译: 本发明涉及通过提供能够调节NCAM的Ig1,Ig2和/或Ig3模块之间的相互作用的化合物来调节呈递细胞的神经细胞粘附分子(NCAM)的分化,粘附和/或存活的方法。 本发明提供能够通过应用中描述的筛选和测试方法调节NCAM的Ig1,Ig2和/或Ig3模块之间的相互作用的候选化合物。 本发明还涉及包含能够调节NCAM的Ig1,Ig2和/或Ig3模块之间的相互作用的化合物的药物组合物,以及用于调节NCAM呈递细胞的分化,粘附和/或存活的药物组合物和化合物 。

    NEURITOGENIC PEPTIDES
    4.
    发明申请
    NEURITOGENIC PEPTIDES 有权
    神经细胞肽

    公开(公告)号:US20090197801A1

    公开(公告)日:2009-08-06

    申请号:US11913954

    申请日:2006-05-08

    摘要: The present invention relates to peptide compounds that are capable of stimulating neuronal differentiation, neurite outgrowth and survival of neural cells, and enhancing synaptic plasticity, learning and memory, methods of treating diseases and conditions of nervous system by administration of compositions comprising said compounds. The compounds and compositions of the invention include peptide sequences that are derived from the sequence of human erythropoietin or proteins that are homologous of human erythropoietin.

    摘要翻译: 本发明涉及能够刺激神经元分化,神经突生长和神经细胞存活的肽化合物,以及通过施用包含所述化合物的组合物来增强突触可塑性,学习和记忆,治疗神经系统的疾病和病症的方法。 本发明的化合物和组合物包括衍生自人促红细胞生成素序列或与促红细胞生成素同源的蛋白质的肽序列。

    Method of Modulating Cell Survival, Differentiation and/or Synaptic Plasticity
    5.
    发明申请
    Method of Modulating Cell Survival, Differentiation and/or Synaptic Plasticity 有权
    调节细胞存活,分化和/或突触可塑性的方法

    公开(公告)号:US20080249004A1

    公开(公告)日:2008-10-09

    申请号:US10574084

    申请日:2004-09-29

    摘要: The present invention relates to a method of modulating differentiation, adhesion and/or survival of the neural cell adhesion molecule (NCAM) presenting cells by providing compounds capable of modulating the interaction between the Ig1, Ig2 and/or Ig3 modules of NCAM. The invention provides candidate compounds capable of modulating the interaction between the Ig1, Ig2 and/or Ig3 modules of NCAM by using methods for screening and testing described in the application. The invention further relates to pharmaceutical compositions comprising compounds capable of modulating the interaction between the Ig1, Ig2 and/or Ig3 modules of NCAM and to use of the pharmaceutical compositions and compounds for the modulation of differentiation, adhesion and/or survival of NCAM presenting cells.

    摘要翻译: 本发明涉及通过提供能够调节NCAM的Ig1,Ig2和/或Ig3模块之间的相互作用的化合物来调节呈递细胞的神经细胞粘附分子(NCAM)的分化,粘附和/或存活的方法。 本发明提供能够通过应用中描述的筛选和测试方法调节NCAM的Ig1,Ig2和/或Ig3模块之间的相互作用的候选化合物。 本发明还涉及包含能够调节NCAM的Ig1,Ig2和/或Ig3模块之间的相互作用的化合物的药物组合物,以及用于调节NCAM呈递细胞的分化,粘附和/或存活的药物组合物和化合物 。

    Survival promoting NCAM binding and MCAM ligand binding compounds
    7.
    发明申请
    Survival promoting NCAM binding and MCAM ligand binding compounds 审中-公开
    生存促进NCAM结合和MCAM配体结合化合物

    公开(公告)号:US20070116702A1

    公开(公告)日:2007-05-24

    申请号:US11637730

    申请日:2006-12-13

    IPC分类号: A61K39/395 A61K38/17

    CPC分类号: A61K38/1774

    摘要: The present invention relates to compounds capable of stimulating survival of cells presenting the neural cell adhesion molecule (NCAM) or an NCAM-ligand (counter-receptor), such as neurons. Further, the present invention relates to the use of pharmaceutical compositions and medicaments in the treatment or protection of cells presenting NCAM or NCAM ligands. More particularly the invention describes the use of a compound comprising a peptide comprising at least 5 contiguous amino acid residues from an amino acid sequence of NCAM, a fragment thereof, or a variant thereof or a mimic thereof, for the preparation of a medicament for preventing cell death of cells presenting said NCAM or an NCAM ligand.

    摘要翻译: 本发明涉及能够刺激呈现神经细胞粘附分子(NCAM)的细胞或NCAM-配体(反受体)如神经元的存活的化合物。 此外,本发明涉及药物组合物和药物在治疗或保护呈现NCAM或NCAM配体的细胞中的用途。 更具体地,本发明描述了使用包含由NCAM的氨基酸序列至少5个连续氨基酸残基的肽组成的化合物,其片段或其变体或其模拟物,用于制备用于预防 呈现所述NCAM或NCAM配体的细胞的细胞死亡。

    Metallothionein-derived peptide fragments
    9.
    发明授权
    Metallothionein-derived peptide fragments 有权
    金属硫蛋白衍生的肽片段

    公开(公告)号:US08618060B2

    公开(公告)日:2013-12-31

    申请号:US12223947

    申请日:2007-02-12

    IPC分类号: A61K38/10

    CPC分类号: C07K14/825 A61K38/00 C07K7/08

    摘要: The present invention relates to neural cell survival, differentiation and proliferation promoting peptide fragments derived from metallothioneins (MT), pharmaceutical compositions comprising said peptide fragments and uses thereof for treatment of diseases and conditions where the effects of stimulating neural cell proliferation, differentiation and/or survival, and/or stimulating neural plasticity associated with learning and memory are beneficial for treatment.

    摘要翻译: 本发明涉及来自金属硫蛋白(MT)的神经细胞存活,分化和增殖促进肽片段,包含所述肽片段的药物组合物及其用于治疗刺激神经细胞增殖,分化和/或 生存和/或刺激与学习和记忆相关的神经可塑性有益于治疗。